{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:47:05Z","timestamp":1772120825853,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T00:00:00Z","timestamp":1657929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ebiom.2022.104196","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T02:47:56Z","timestamp":1659581276000},"page":"104196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in na\u00efve hamsters compared to ancestral vaccine"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8233-8176","authenticated-orcid":false,"given":"David W.","family":"Hawman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Meade-White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Archer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troy","family":"Hinkley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanna S.","family":"Leventhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepashri","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allie","family":"Stamper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Rosenke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Randall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit P.","family":"Khandhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linhue","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tien-Ying","family":"Hsiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander L.","family":"Greninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Michael","family":"Gale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Berglund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah Heydenburg","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Rosenke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse H.","family":"Erasmus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ebiom.2022.104196_bib0001","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape","volume":"21","author":"Tregoning","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"7871","key":"10.1016\/j.ebiom.2022.104196_bib0002","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization","volume":"596","author":"Planas","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104196_bib0003","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41591-021-01318-5","article-title":"Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies","volume":"27","author":"Planas","year":"2021","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104196_bib0004","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","article-title":"The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104196_bib0005","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.chom.2021.01.014","article-title":"Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization","volume":"29","author":"Liu","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ebiom.2022.104196_bib0006","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","article-title":"Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa","volume":"603","author":"Viana","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104196_bib0007","unstructured":"CDC. COVID Data Tracker. 2022."},{"issue":"10325","key":"10.1016\/j.ebiom.2022.104196_bib0008","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0140-6736(22)00090-3","article-title":"Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose","volume":"399","author":"Kuhlmann","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104196_bib0009","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/22221751.2021.2022440","article-title":"Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost","volume":"11","author":"Ai","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ebiom.2022.104196_bib0010","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2119236","article-title":"SARS-CoV-2 omicron variant neutralization in serum from vaccinated and convalescent persons","author":"R\u00f6ssler","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2022.104196_bib0011","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-022-04399-5","article-title":"Activity of convalescent and vaccine serum against SARS-CoV-2 omicron","volume":"602","author":"Carre\u00f1o","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104196_bib0012","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","article-title":"Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding","volume":"182","author":"Starr","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2022.104196_bib0013","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41586-021-04245-0","article-title":"The N501Y spike substitution enhances SARS-CoV-2 infection and transmission","volume":"602","author":"Liu","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104196_bib0014","article-title":"The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters","author":"Diamond","year":"2021","journal-title":"Res Sq"},{"key":"10.1016\/j.ebiom.2022.104196_bib0015","doi-asserted-by":"crossref","unstructured":"Lyngse FP, Kirkeby CT, Denwood M, et al. Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: evidence from Danish households. medRxiv. 2022:2022.01.28.22270044.","DOI":"10.1101\/2022.01.28.22270044"},{"key":"10.1016\/j.ebiom.2022.104196_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/d41587-022-00001-5","article-title":"COVID-19 vaccine makers chase variant-ready vaccines","author":"Sheridan","year":"2022","journal-title":"Nat Biotechnol"},{"issue":"555","key":"10.1016\/j.ebiom.2022.104196_bib0017","doi-asserted-by":"crossref","first-page":"eabc9396","DOI":"10.1126\/scitranslmed.abc9396","article-title":"An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates","volume":"12","author":"Erasmus","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2022.104196_bib0018","doi-asserted-by":"crossref","first-page":"e75537","DOI":"10.7554\/eLife.75537","article-title":"SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern","volume":"11","author":"Hawman","year":"2022","journal-title":"eLife"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104196_bib0019","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.4269\/ajtmh.21-0229","article-title":"Inactivation of SARS-CoV-2 laboratory specimens","volume":"104","author":"Haddock","year":"2021","journal-title":"Am J Trop Med Hygiene"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104196_bib0020","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02226-20","article-title":"Sensitive recovery of complete SARS-CoV-2 genomes from clinical samples by use of swift biosciences' SARS-CoV-2 multiplex amplicon sequencing panel","volume":"59","author":"Addetia","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104196_bib0021","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Euro Surveill"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104196_bib0022","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints12","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ebiom.2022.104196_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105253","article-title":"The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters","volume":"198","author":"Abdelnabi","year":"2022","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ebiom.2022.104196_bib0024","doi-asserted-by":"crossref","unstructured":"Ryan KA, Watson RJ, Bewley KR, et al. Convalescence from prototype SARS-CoV-2 protects Syrian hamsters from disease caused by the Omicron variant. bioRxiv: the preprint server for biology. 2021:2021.12.24.474081.","DOI":"10.1101\/2021.12.24.474081"},{"key":"10.1016\/j.ebiom.2022.104196_bib0025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41586-022-04441-6","article-title":"SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters","volume":"603","author":"Halfmann","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104196_bib0026","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMc2119641","article-title":"Plasma neutralization of the SARS-CoV-2 omicron variant","volume":"386","author":"Schmidt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2022.104196_bib0027","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41591-021-01676-0","article-title":"mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant","volume":"28","author":"Gruell","year":"2022","journal-title":"Nat Med"},{"issue":"6593","key":"10.1016\/j.ebiom.2022.104196_bib0028","doi-asserted-by":"crossref","first-page":"eabn4947","DOI":"10.1126\/science.abn4947","article-title":"Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa","volume":"376","author":"Pulliam","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2022.104196_bib0029","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41586-021-04387-1","article-title":"Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization","volume":"602","author":"Cele","year":"2021","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104196_bib0030","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.chom.2021.06.016","article-title":"The success of SARS-CoV-2 vaccines and challenges ahead","volume":"29","author":"Subbarao","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ebiom.2022.104196_bib0031","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2108891","article-title":"Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant","volume":"385","author":"Lopez Bernal","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104196_bib0032","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41591-022-01700-x","article-title":"Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant","volume":"28","author":"Gao","year":"2022","journal-title":"Nat Med"},{"issue":"7901","key":"10.1016\/j.ebiom.2022.104196_bib0033","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-022-04465-y","article-title":"Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron","volume":"603","author":"Liu","year":"2022","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104196_bib0034","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/s41591-021-01527-y","article-title":"Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis","volume":"27","author":"Choi","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2022.104196_bib0035","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMc2119912","article-title":"SARS-CoV-2 omicron variant neutralization after mRNA-1273 booster vaccination","volume":"386","author":"Pajon","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104196_bib0036","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038786","article-title":"Original antigenic sin: how original? How sinful?","volume":"11","author":"Yewdell","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6581","key":"10.1016\/j.ebiom.2022.104196_bib0037","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.abn7591","article-title":"Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine\u2013elicited human sera","volume":"375","author":"Muik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2022.104196_bib0038","doi-asserted-by":"crossref","unstructured":"van der Straten K, Guerra D, van Gils MJ, et al. Mapping the antigenic diversification of SARS-CoV-2. medRxiv. 2022:2022.01.03.21268582.","DOI":"10.1101\/2022.01.03.21268582"},{"issue":"6577","key":"10.1016\/j.ebiom.2022.104196_bib0039","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1126\/science.abm0811","article-title":"Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants","volume":"375","author":"Reynolds","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2022.104196_bib0040","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.cell.2022.03.038","article-title":"mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing antibodies and protection against Omicron","volume":"185","author":"Gagne","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2022.104196_bib0041","unstructured":"Bowen JE, Sprouse KR, Walls AC, et al. Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines. bioRxiv: the preprint server for biology. 2022:2022. 03.15.484542."},{"key":"10.1016\/j.ebiom.2022.104196_bib0042","doi-asserted-by":"crossref","first-page":"139","DOI":"10.15585\/mmwr.mm7104e3","volume":"71","author":"Thompson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6572","key":"10.1016\/j.ebiom.2022.104196_bib0043","doi-asserted-by":"crossref","first-page":"abm0829","DOI":"10.1126\/science.abm0829","article-title":"mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern","volume":"374","author":"Goel","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2022.104196_bib0044","unstructured":"Rabinovitch A. Israeli study shows 4th shot of COVID-19 vaccine less effective on Omicron. 2022."},{"key":"10.1016\/j.ebiom.2022.104196_bib0045","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1056\/NEJMoa2201570","article-title":"Protection by a fourth dose of BNT162b2 against omicron in Israel","volume":"386","author":"Bar-On","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2022.104196_bib0046","doi-asserted-by":"crossref","unstructured":"Ying B, Scheaffer SM, Whitener B, et al. Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice. bioRxiv: the preprint server for biology. 2022:2022.02.07.479419.","DOI":"10.1101\/2022.02.07.479419"},{"key":"10.1016\/j.ebiom.2022.104196_bib0047","article-title":"India's biggest cities see covid-19 cases fall sharply, raising hopes for omicron peak","author":"Agarwal","year":"2022","journal-title":"Wall Street J"},{"key":"10.1016\/j.ebiom.2022.104196_bib0048","first-page":"o7","article-title":"South Africa says fourth wave peak has passed as it lifts curfew","volume":"376","author":"Omicron","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.ebiom.2022.104196_bib0049","doi-asserted-by":"crossref","first-page":"o163","DOI":"10.1136\/bmj.o163","article-title":"Covid-19: England prepares to ease plan B restrictions","volume":"376","author":"Wise","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.ebiom.2022.104196_bib0050","unstructured":"Devlin H, Kollewe J. BioNTech says it could tweak Covid vaccine in 100 days if needed. Guardian (newspaper) https:\/\/www.theguardian.com\/society\/2021\/nov\/26\/biontechsays-it-could-tweak-covid-vaccine-in-100-days-if-needed. Accessed 13 December 2021."},{"issue":"9","key":"10.1016\/j.ebiom.2022.104196_bib0051","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/cid\/ciaa325","article-title":"Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a Golden Syrian Hamster model: implications for disease pathogenesis and transmissibility","volume":"71","author":"Chan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2022.104196_bib0052","article-title":"Efficacy of ChAdOx1 vaccines against SARS-CoV-2 variants of concern beta, delta and omicron in the Syrian hamster model","author":"van Doremalen","year":"2022","journal-title":"Res Sq"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422003784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422003784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:17:14Z","timestamp":1762456634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422003784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":52,"alternative-id":["S2352396422003784"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104196","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.01.31.478520","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in na\u00efve hamsters compared to ancestral vaccine","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104196"}}